Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: Spironolactone and XPB-1 Integrity in the TFIIH Complex [NA]

View source ↗

Summary

An ongoing clinical trial sponsored by University of Sao Paulo General Hospital is studying spironolactone in relation to XPB-1 integrity within the TFIIH compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: HIV | NA | Status: ENROLLING_BY_INVITATION